Prescient Therapeutics : Capital Raising Presentation - March 2019

CAPITAL RAISING PRESENTATION MARCH 2019

Prescient Therapeutics Limited (ASX: PTX)

March 2019

NOT FOR RELEASE TO U.S. WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES EXCEPT TO APPROVED U.S. INVESTORS

Forward-looking statements

Certain statements made in this document are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are not historical facts but rather are based on the current expectations of Prescient Therapeutics Limited ("Prescient" or the "Company"), their estimates, assumptions, and projections about the industry in which Prescient operates. Material referred to in this document that use the words 'estimate', 'project', 'intend', 'expect', 'plan', 'believe', 'guidance', and similar expressions are intended to identify forward-looking statements and should be considered an at-risk statement. These forward-looking statements are not a guarantee of future performance and involve known and unknown risks and uncertainties, some of which are beyond the control of Prescient or which are difficult to predict, which could cause the actual results, performance, or achievements of Prescient to be materially different from those which may be expressed or implied by these statements. These statements are based on our management's current expectations and are subject to a number of uncertainties and risks that could change the results described in the forward-looking statements. Risks and uncertainties include, but are not limited to, general industry conditions and competition, general economic factors, the impact of pharmaceutical industry development and health care legislation in the United States and internationally, and challenges inherent in new product development. Investors should be aware that there are no assurances that results will not differ from those projected and Prescient cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of Prescient only as of the date of this presentation. Prescient is not under a duty to update any forward-looking statement as a result of new information, future events or otherwise, except as required by law or by any appropriate regulatory authority. Certain statements contained in this document, including, without limitation, statements containing the words "believes," "plans," "expects," "anticipates," and words of similar import, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Prescient to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following: the risk that our clinical trials will be delayed and not completed on a timely basis; the risk that the results from the clinical trials are not as favorable as we anticipate; the risk that our clinical trials will be more costly than anticipated; and the risk that applicable regulatory authorities may ask for additional data, information or studies to be completed or provided prior to their approval of our products. Given these uncertainties, undue reliance should not be placed on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the results of any revisions to any of the forward-looking statements contained herein to reflect future events or developments except as required by law.

Confidentiality

The contents of this document are confidential information of the Company. These contents are made available on a 'for your eyes only' basis to the person to whom it was sent by the Company. The purpose of the disclosure is to facilitate commercial and confidential discussions between the disclosee and the Company. It should not be forwarded without without the prior written consent of the Company.

TARGETED THERAPIES

YIELDING A DEEP CLINICAL PIPELINE

Summary information

This document may not contain all the details and information necessary for you to make a decision or evaluation. This document contains summary information about the Company and its activities which is current only as at the date of this document. The information in this document is of a general nature and does not purport to be complete. It does not purport to summarise all information than an investor may require or that would be required to be included in a prospectus or product disclosure statement prepared in accordance with the Corporations Act when making an investment decision. It should be read in conjunction with the Company's other periodic and continuous disclosure announcements lodged with the Australian Securities Exchange (ASX), which are available atwww.asx.com.au.

Statutory, proforma and underlying information

Statutory information is based on reviewed financial statements. "Proforma" and "underlying" financial information has not been audited or reviewed. The pro-forma financial information included in this presentation is for illustrative purposes and does not purport to be in compliance with Article 11 of Regulation S-X of the rules and regulations of the U.S. Securities and Exchange Commission. Investors should be aware that financial data in this presentation include "non-IFRS financial information" under ASIC Regulatory Guide 230 "Disclosing non-IFRS financial information" published by ASIC and also "non-GAAP financial measures" within the meaning of Regulation G under the U.S. Securities Exchange Act of 1934. Non-IFRS/non-GAAP measures ireferred to n this presentation include without limitation the following: Profroma Cash Position, Market Capitalisation and [insert any others]. Although the directors of the Company believe these non-IFRS/non-GAAP financial measures provide useful information about the financial performance of the Company, they should be considered as indications or supplements to those measures that have been presented in accordance with the Australian Accounting Standards and not as a replacement for them. The non-IFRS /non-GAAP financial measures do not have a standardised meaning prescribed by Australian Accounting Standards and, therefore, may not be comparable to similarly titled measures presented by other entities, nor should they be construed as an alternative to other financial measures determined in accordance with Australian Accounting Standards. Readers are cautioned, therefore, not to place undue reliance on any non-IFRS/non-GAAP financial measures included in this presentation.

Past performance

The Company's past performance and position reflected in this document is given for illustrative purposes only and should not be relied upon as (and is not) an indication of the Company's views on its future financial performance or condition. Investors should note that past performance, including past share price performance, of the Company cannot be relied upon as an indicator of (and provides no guidance as to) future Company performance including future share price performance. The historical ginancial Information included in this document is, or is based on, information that has previously been released to the market.

Participation in the Offer

Determination of eligibility of investors for the purposes of the Capital Raising will be by reference to a number of matters, including legal and regulatory requirements, logistical and registry constraints and the discretion of the Company. The Company and its advisers, affiliates, related bodies corporate, directors, officers, partners, employees and agents disclaim any duty or liability (including for negligence) in respect of that determination and the exercise or otherwise of that discretion, to the maximum extent permitted by law. See the section of this document entitled "International Offer Restrictions" for restrictions on residents in certain other jurisdictions outside of Australiaon for participation in the Capital Raising .

Not a regulated offer document

This document is for information purposes only and is not a prospectus, product disclosure statement or other offer document under Australian law or the law of any other jurisdiction. This presentation is not and should not be considered, and does not purport to contain, an offer, invitation, solicitation or recommendation with respect to the Capital Raising in any jurisdiction. The information booklet for the Entitlement Offer will be available following its lodgement with ASX. Any eligible shareholder who wishes to participate in the Entitlement Offer should consider the infromation booklet in deciding whether to apply under that offer. Anyone who wishes to participate in the Entitlement Offer under the Capital Raising will need to apply in accordance with the instructions contained in the information booklet and the entitlement and acceptance form that will accompany it.

Not for release or distribution in the United States

This document may not be released or distributed in the United States except to Approved U.S. Investors. This presentation does not constitute an invitation or offer of securities for subscription, purchase or sale in the United States or any other jurisdiction in which such an offer would be illegal. The securities referred to in this presentation have not been, and will not be, registered under the U.S. Securities Act of 1933 as amended (the "Securities Act") or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly in the United States or to any person acting for the account or benefit of a person in the United States unless the securities have been registered under the Securities Act (which the Company has no obligation to do or procure) or are offered and sold in a transaction exempt from, or not subject to, the registration requirements of the Securities Act and any other applicable securities laws. The distribution of this presentation in jurisdictions outside Australia may be restricted by law and you should observe any such restrictions.

Not financial product or investment advice

This document is not financial product or investment advice, a recommendation to participate in the Capital Riasing or accounting, legal or tax advice. It has been prepared without taking into account the objectives, financial or tax situation or needs of individuals. Before making an investment decision, prospective investors should consider the appropriateness of the information having regard to their own objectives, financial and tax situation and needs and seek legal and taxation advice appropriate to their jurisdiction. The Company is not licensed to provide financial product advice in respect of the Capital Raising. Cooling off rights do not apply to the Capital Raising. Neither this presentation nor anything contained in it shall form the basis of any contract or commitment and it is not intended to induce or solicit any person to engage in, or refrain from engaging in, any transaction.

Disclaimer

The Company makes no warranty concerning the Caital Raising referred to in this document. The Company makes no representation or warranty, express or implied, as to the fairness, accuracy or completeness of the information, opinions and conclusions contained in this document by any person and, to the maximum extent permitted by law, the Comapny disclaims all liability for any loss arising from the use of this document or its contents or otherwise arising in connection with it. Further, the Company accepts no fiduciary obligations to or in relation with any investor or potential investor in connection with the Capital Raising, or otherwise, and by accepting this document each recipient expressly disclaims any fiduciary relationship and agrees that it is responsible for making its own independent judgements with respect to the referred to in this document, and any other transaction or other matter arising in connection with this document. The placement referred to in this document is only available in Australia to certain persons who are professional investors or wholesale clients or other persons specified in section 708 of the Corporations Act to whom a disclosure document is not required to be given under Chapter 6D of the Corporations Act.